CompletedPhase 2/3

Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial

504 participantsStarted 2011-03

Plain-language summary

The objective of the study is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised cancer patients. This is a before-after cluster phase II study performed in medicine, oncology and respiratory disease hospital wards. The Pac-IFicO programme is a complex interventions with multiple components. The primary end-point of the study is the proportion of cancer patients with severe pain.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. consent from the head of the ward to participate to the study;
✓. ward classified as oncology, medicine, respiratory disease ward according to the regional classification of hospitals;
✓. number of beds: ≥20 ;
✓. number of ordinary admissions with primary or secondary diagnosis of tumour (ICD-IX 140-239) \>180 per year;
✓. yearly average stay in hospital between 4 and 19 days;
✓. punctual prevalence of patients with primary or secondary diagnosis of tumour (ICD-IX 140-239) ≥ 8 patients.
✓. affiliation to the ward;
✓. informed consent to participate to the study.

What they're measuring

percentage of hospitalized cancer patients with average severe pain (score 7-10) within the latest 24 hours

Timeframe: up to 28±1 days after Pac-IficO completion.

Trial details

NCT IDNCT02035098

SponsorAzienda USL Reggio Emilia - IRCCS

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2012-07

View on ClinicalTrials.gov More Cancer trials